Latest Insider Transactions at Vir Biotechnology, Inc. (VIR)
This section provides a real-time view of insider transactions for Vir Biotechnology, Inc. (VIR). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Vir Biotechnology, Inc. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Vir Biotechnology, Inc.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Aug 25
2022
|
Robert Nelsen Director |
BUY
Other acquisition or disposition
|
Indirect |
1,684
+5.84%
|
-
|
|
Aug 25
2022
|
Robert Nelsen Director |
BUY
Other acquisition or disposition
|
Direct |
27,489
+5.64%
|
-
|
|
Aug 25
2022
|
Robert Nelsen Director |
SELL
Other acquisition or disposition
|
Indirect |
500,000
-3.24%
|
-
|
|
Aug 25
2022
|
Arch Venture Partners Ix, LLC > 10% Shareholder |
BUY
Other acquisition or disposition
|
Indirect |
2,952
+5.64%
|
-
|
|
Aug 25
2022
|
Arch Venture Partners Ix, LLC > 10% Shareholder |
BUY
Other acquisition or disposition
|
Direct |
14,551
+5.62%
|
-
|
|
Aug 25
2022
|
Arch Venture Partners Ix, LLC > 10% Shareholder |
SELL
Other acquisition or disposition
|
Indirect |
500,000
-3.24%
|
-
|
|
Aug 24
2022
|
Robert Nelsen Director |
BUY
Other acquisition or disposition
|
Indirect |
1,684
+6.2%
|
-
|
|
Aug 24
2022
|
Robert Nelsen Director |
BUY
Other acquisition or disposition
|
Direct |
27,489
+5.97%
|
-
|
|
Aug 24
2022
|
Robert Nelsen Director |
SELL
Other acquisition or disposition
|
Indirect |
500,000
-3.14%
|
-
|
|
Aug 24
2022
|
Arch Venture Partners Ix, LLC > 10% Shareholder |
BUY
Other acquisition or disposition
|
Indirect |
2,952
+5.98%
|
-
|
|
Aug 24
2022
|
Arch Venture Partners Ix, LLC > 10% Shareholder |
BUY
Other acquisition or disposition
|
Direct |
14,551
+5.95%
|
-
|
|
Aug 24
2022
|
Arch Venture Partners Ix, LLC > 10% Shareholder |
SELL
Other acquisition or disposition
|
Indirect |
500,000
-3.14%
|
-
|
|
Aug 18
2022
|
Robert Nelsen Director |
BUY
Other acquisition or disposition
|
Indirect |
1,684
+6.61%
|
-
|
|
Aug 18
2022
|
Robert Nelsen Director |
BUY
Other acquisition or disposition
|
Direct |
27,489
+6.35%
|
-
|
|
Aug 18
2022
|
Robert Nelsen Director |
SELL
Other acquisition or disposition
|
Indirect |
500,000
-3.05%
|
-
|
|
Aug 18
2022
|
Arch Venture Partners Ix, LLC > 10% Shareholder |
BUY
Other acquisition or disposition
|
Indirect |
2,952
+6.36%
|
-
|
|
Aug 18
2022
|
Arch Venture Partners Ix, LLC > 10% Shareholder |
BUY
Other acquisition or disposition
|
Direct |
14,551
+6.33%
|
-
|
|
Aug 18
2022
|
Arch Venture Partners Ix, LLC > 10% Shareholder |
SELL
Other acquisition or disposition
|
Indirect |
500,000
-3.05%
|
-
|
|
Aug 16
2022
|
Svf Endurance (Cayman) LTD > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
7,800
-0.04%
|
$210,600
$27.64 P/Share
|
|
Aug 16
2022
|
Robert Nelsen Director |
BUY
Other acquisition or disposition
|
Indirect |
1,684
+7.08%
|
-
|
|
Aug 16
2022
|
Robert Nelsen Director |
BUY
Other acquisition or disposition
|
Direct |
27,489
+6.78%
|
-
|
|
Aug 16
2022
|
Robert Nelsen Director |
SELL
Other acquisition or disposition
|
Indirect |
500,000
-2.96%
|
-
|
|
Aug 16
2022
|
Arch Venture Partners Ix, LLC > 10% Shareholder |
BUY
Other acquisition or disposition
|
Indirect |
2,952
+6.8%
|
-
|
|
Aug 16
2022
|
Arch Venture Partners Ix, LLC > 10% Shareholder |
BUY
Other acquisition or disposition
|
Direct |
14,551
+6.76%
|
-
|
|
Aug 16
2022
|
Arch Venture Partners Ix, LLC > 10% Shareholder |
SELL
Other acquisition or disposition
|
Indirect |
500,000
-2.96%
|
-
|
|
Aug 15
2022
|
Svf Endurance (Cayman) LTD > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
122,564
-0.28%
|
$3,309,228
$27.99 P/Share
|
|
Aug 15
2022
|
Robert Nelsen Director |
BUY
Other acquisition or disposition
|
Indirect |
1,684
+7.61%
|
-
|
|
Aug 15
2022
|
Robert Nelsen Director |
BUY
Other acquisition or disposition
|
Direct |
27,489
+7.28%
|
-
|
|
Aug 15
2022
|
Robert Nelsen Director |
SELL
Other acquisition or disposition
|
Indirect |
500,000
-2.87%
|
-
|
|
Aug 15
2022
|
Arch Venture Partners Ix, LLC > 10% Shareholder |
BUY
Other acquisition or disposition
|
Indirect |
2,952
+7.29%
|
-
|
|
Aug 15
2022
|
Arch Venture Partners Ix, LLC > 10% Shareholder |
BUY
Other acquisition or disposition
|
Direct |
14,551
+7.25%
|
-
|
|
Aug 15
2022
|
Arch Venture Partners Ix, LLC > 10% Shareholder |
SELL
Other acquisition or disposition
|
Indirect |
500,000
-2.87%
|
-
|
|
Aug 12
2022
|
Robert Nelsen Director |
BUY
Other acquisition or disposition
|
Indirect |
1,684
+8.24%
|
-
|
|
Aug 12
2022
|
Robert Nelsen Director |
BUY
Other acquisition or disposition
|
Direct |
27,489
+7.85%
|
-
|
|
Aug 12
2022
|
Robert Nelsen Director |
SELL
Other acquisition or disposition
|
Indirect |
500,000
-2.79%
|
-
|
|
Aug 12
2022
|
Arch Venture Partners Ix, LLC > 10% Shareholder |
BUY
Other acquisition or disposition
|
Indirect |
2,952
+7.86%
|
-
|
|
Aug 12
2022
|
Arch Venture Partners Ix, LLC > 10% Shareholder |
BUY
Other acquisition or disposition
|
Direct |
14,551
+7.81%
|
-
|
|
Aug 12
2022
|
Arch Venture Partners Ix, LLC > 10% Shareholder |
SELL
Other acquisition or disposition
|
Indirect |
500,000
-2.79%
|
-
|
|
Aug 09
2022
|
Herbert Virgin EVP, Research & CSO |
BUY
Exercise of conversion of derivative security
|
Direct |
78,093
+12.27%
|
$390,465
$5.96 P/Share
|
|
Aug 08
2022
|
Vicki L Sato Director |
SELL
Open market or private sale
|
Direct |
17,915
-1.22%
|
$537,450
$30.29 P/Share
|
|
Jul 20
2022
|
Phillip Pang EVP & Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
5,000
-3.36%
|
$150,000
$30.0 P/Share
|
|
Jul 20
2022
|
Phillip Pang EVP & Chief Medical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
5,000
+3.25%
|
$5,000
$1.57 P/Share
|
|
Jul 11
2022
|
Saira Ramasastry Director |
SELL
Open market or private sale
|
Direct |
5,000
-38.19%
|
$150,000
$30.0 P/Share
|
|
Jul 11
2022
|
Saira Ramasastry Director |
BUY
Grant, award, or other acquisition
|
Direct |
5,000
+27.64%
|
$60,000
$12.76 P/Share
|
|
Jul 08
2022
|
Vicki L Sato Director |
SELL
Open market or private sale
|
Direct |
17,915
-0.6%
|
$519,535
$29.22 P/Share
|
|
Jun 21
2022
|
Phillip Pang EVP & Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
4,991
-3.35%
|
$119,784
$24.89 P/Share
|
|
Jun 09
2022
|
Robert J More Director |
BUY
Other acquisition or disposition
|
Indirect |
3,374
+0.68%
|
-
|
|
Jun 09
2022
|
Robert J More Director |
SELL
Other acquisition or disposition
|
Direct |
3,374
-7.95%
|
-
|
|
Jun 08
2022
|
Robert Nelsen Director |
BUY
Other acquisition or disposition
|
Indirect |
1,684
+8.98%
|
-
|
|
Jun 08
2022
|
Robert Nelsen Director |
BUY
Other acquisition or disposition
|
Direct |
27,489
+8.52%
|
-
|